A Way to Concur Cancer with Eric Lefkofsky

Eric Lefkofsky created Tempus when he hadn’t entered a science class since college. The company is attempting to merge artificial intelligence ad healthcare. Eric was at the age of 49 when he launched five companies that totaled approximately $250 million each. All of the companies promise to transform the health industry by using entered data. Tempus is designed to be use by doctors utilizing the information stored in order to personalize cancer treatments. Eventually, making them more effective.

An example is a doctor treating a patient with lung cancer, but he may send tumor biopsy to Tempus for sequencing. Tempus will take that sample and identify the mutation in the gene for epidermal growth. This is what causes the cells to grow and divide on a non-normal level. Then the doctor will prescribe a specific therapy that performs better than chemotherapy. The company consists of 700-employee and has raised $520 million.

Eric’s company, Tempus, also license a library of data that pushes out information to drug companies, providers, and researchers. Lefkofsky attended the University of Michigan, where he studied history, but had a sudden urge to be an entrepreneur. Andrew Mason was one of Eric’s first hires and he pitched an idea for a business venture to Lefkofsky. In which, Lefkpfsky decided to invest $1 million. This company that Andrew spoke of became the leading discount sight named Groupon.

In 2014, Lefkofsky’s wife, Liz, was diagnosed with breast cancer.

After this discovery. Eric Lefkofsky started another startup called Concerto Health AI. The new health startup company was supported by Romesh Wadhwani. The company is similar in build to Tempus. Whereas the doctors at UC Davis are now involve with Tempus, they are one of the few that have only sent about 100 samples to Tempus. This is considerably fewer samples sent than what they have shipped out to another genetic sample company named Foundation.

Eric Lefkofsky Continues To Give Back

Tempus is one of the leading providers of technology precision medicine. The company was co-founded by Eric Lefkofsky. Eric Lefkofsky is not just very successful entrepreneur and self-made billionaire but he is also a philanthropist. Tempus was founded to help patients and provide better medical care throughout the entire health care system. Eric Lefkosky has a heavy background when it comes to co-founding businesses. He has several startups under his belt such as Groupon, Lightbank, Echo Global Logistics, and these are just a few but there are many more. The thing about Eric Lefkofsky is that he isn’t focused on money and he gives a lot back to the community. He currently has a foundation called the Lefkofsky Family Foundation and he started this Foundation back in 2006. Having a caring nature and a giving spirit is just a part of who he is. He is extremely well-educated and attendant the University of Michigan and graduated with his bachelor degree. After completing his bachelor degree he then went on to attend the University of Michigan Law School and graduated with his doctor in Juris degree.

The goal of Eric Leftkofsky and Tempus is to create the world’s largest clinical and molecular database. The thought process behind this is that it can improve patient care and assist in the fight against cancer. If they accomplish this and make this operating system very effective and efficient physicians will have a more in depth medical record that will enable them to create an individualized plan of care for each specific cancer patient. Tempus continues to grow the startup has currently raised another 200 million for cancer, diabetes, and depression research. The company was started 3 years ago and has made major strides. They have hired over 700 staff which includes scientists, researchers, clinicians, and many other disciplines that are required in his fight against cancer, diabetes, and depression.

Eric Leftkosky is truly a selfless individual. He and his team at Tempus are doing some great work when it comes to cancer research and improving patient care for cancer patients. What is even more impressive is that the company did not stop there but instead they joined in on the fight against diabetes and depression. These are two other serious disorders that need to be combated, have better treatment, or possibly find a cure for. I admire a healthcare research company that is about the people and not all about the profit.